Renal Transplantation – Mechanisms and Management of Early Rejection

Sayegh, 2004, Transplantation 50 years late -progress, challenges and promises, N Eng J Med, 351, 2761, 10.1056/NEJMon043418 Deuton, 1999, Immuno-suppressive strategies in transplantation, Lancet, 353, 1083, 10.1016/S0140-6736(98)07493-5 Womer, 2000, Chronic allograft dysfunction: Mechanisms and new approaches to therapy, Semin Nephrol, 20, 126 US transplant - Scientific registry of transplant recipients 2005 OPTN/SRTR annual report Ann Arbor, MI: University Renal Research and Education association with the University of Michigan, 2005. Perico, 2004, Delayed graft function in kidney transplantation, Lancet, 364, 1814, 10.1016/S0140-6736(04)17406-0 Ojo, 1997, Delayed graft function: Risk factors and Implications for renal allograft survival, Transplantation, 63, 968, 10.1097/00007890-199704150-00011 Helderman, 2001, Transplantation immunobiology, 17 Vincenti, 2005, A drug of the past, a lesson for the future, Pediatr Transplant, 9, 267, 10.1111/j.1399-3046.2005.00332.x Magliocco, 2006, The evolving role of alemtuzumab (Campath IH) for immunosuppressive therapy in organ transplantation, Transplant Int, 19, 705, 10.1111/j.1432-2277.2006.00343.x Adu, 2003, Interleukin 2 receptor monoclonal antibodies in renal transplant recipients: A meta analysis of randomised trials, BMJ, 326, 789, 10.1136/bmj.326.7393.789 Woodle, 1996, A multicenter trial of tacrolimus therapy in refractory acute renal allograft rejection. A report of the tacrolimus kidney transplantation rescue study group, Transplantation, 62, 594, 10.1097/00007890-199609150-00009